Form 4: DENTSPLY SIRONA Director Gregory Lucier Increases Holdings Through RSU Dividends

DENTSPLY SIRONA Director Gregory T. Lucier acquired 202.777 shares of common stock through dividend reinvestment on restricted stock units, increasing his total beneficial ownership.

Summary

• Gregory T. Lucier, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 202.777 shares of common stock on July 11, 2025.
• The acquisition was at a price of $0 per share, representing dividends on previously awarded restricted stock units (RSUs) in the form of additional RSUs.
• These newly acquired RSUs are subject to the same vesting terms as the underlying awards and vest simultaneously, converting to common stock on a 1:1 basis.
• Following this transaction, Gregory Lucier beneficially owns 102,490.434 shares directly and 21,000 shares indirectly through his Gregory Lucier IRA.
• A Limited Power of Attorney was granted by Gregory T. Lucier on May 22, 2025, to Richard Rosenzweig, Jessica Causey, and Lindi Barton-Brobst to execute and file Section 16 reports on his behalf.

Sentiment

Score: 7

Explanation: The acquisition of additional shares by a director, even through RSU dividends, generally indicates continued confidence in the company's future performance and aligns management interests with shareholders.

Positives

• Director Gregory T. Lucier increased his beneficial ownership in DENTSPLY SIRONA Inc., indicating continued participation and alignment of interests with shareholders.
• The acquisition through RSU dividends is a standard component of executive compensation, reflecting ongoing engagement.

Future Outlook

No specific forward-looking statements or guidance are provided beyond the nature of the RSU dividends being subject to the same vesting terms as the underlying awards.

Industry Context

This Form 4 filing details a routine insider transaction related to director compensation, which is common across publicly traded companies. It does not provide broader industry-specific context or trends.

Comparison to Industry Standards

• Insider acquisitions, even through routine RSU dividend reinvestment, are generally viewed as a positive signal of management's confidence in the company's prospects, aligning with common investor sentiment regarding insider ownership.
• The use of Restricted Stock Units (RSUs) as a compensation mechanism, including dividend reinvestment, is a standard practice in corporate executive and director compensation across various industries, including the healthcare and dental technology sectors where DENTSPLY SIRONA operates.

Corporate Governance

Related Party Transactions

• Acquisition of 202.777 shares of common stock by Director Gregory T. Lucier, representing dividends on restricted stock units (RSUs) awarded by DENTSPLY SIRONA Inc. This is a standard transaction between the company and a director as part of compensation.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholders due to increased beneficial ownership, potentially signaling confidence in the company's future.
• Management: Streamlined compliance for Section 16 reporting through the Power of Attorney, reducing administrative burden on the director.

Next Steps

• Continued vesting of the underlying Restricted Stock Units (RSUs) and the newly acquired RSU dividends.
• Ongoing Section 16 reporting obligations for Gregory T. Lucier, facilitated by the established Power of Attorney.

Key Dates

Keywords

DENTSPLY SIRONA Inc., XRAY, Form 4, Insider Transaction, Director Stock Acquisition, Restricted Stock Units, RSU Dividends, Beneficial Ownership, Corporate Governance, SEC Filing